35 results on '"Lou, Wei"'
Search Results
2. Soil microbial community assembly model in response to heavy metal pollution
3. Anticancer potential of cardiac glycosides and steroid-azole hybrids
4. Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer
5. Lin28 Promotes Growth of Prostate Cancer Cells and Activates the Androgen Receptor
6. MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells
7. Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells
8. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4 +CD25 +Foxp3 + T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis
9. INTERLEUKIN-6 POLYMORPHISM IS ASSOCIATED WITH MORE AGGRESSIVE PROSTATE CANCER
10. Selective Activation Of Members Of The Signal Transducers And Activators Of Transcription Family In Prostate Carcinoma
11. MP52-01 COMBINATION OF INDOMETHACIN AND ENZALUTAMIDE TO TREAT CASTRATION-RESISTANT PROSTATE CANCER
12. MP29-08 HSD3B1 PREFERENTIALLY UTILIZES PREGNENOLONE TO PROMOTE RESISTANCE TO ANTI-ANDROGENS IN PROSTATE CANCER
13. MP29-02 ELUCIDATING CROSS-RESISTANCE BETWEEN TAXANES AND NEXT-GENERATION ANTI-ANDROGENS IN CASTRATION RESISTANT PROSTATE CANCER
14. MP99-15 TAXANE RESISTANCE IN PROSTATE CANCER: A ROLE FOR MIRNA 181A
15. MP99-02 OVEREXPRESSION OF HSD3B1 CONFERS RESISTANCE TO ENZALUTAMIDE IN PROSTATE CANCER
16. MP83-09 ELUCIDATING CROSS-RESISTANCE BETWEEN DOCETAXEL AND CABAZITAXEL IN CASTRATION RESISTANT PROSTATE CANCER
17. MP57-19 TARGETING AKR1C3 ACTIVATION BY INDOMETHACIN OVERCOMES RESISTANCE TO ENZALUTAMIDE AND ABIRATERONE
18. PD37-12 EVALUATION OF NICLOSAMIDE AS A POTENT INHIBITOR OF ANDROGEN RECEPTOR VARIANTS TO OVERCOME RESISTANCE TO ABIRATERONE AND ENZALUTAMIDE IN ADVANCED PROSTATE CANCER
19. Transcriptional regulation of human RANK ligand gene expression by E2F1
20. MP46-01 AKR1C3 ACTIVATION AND INTRACRINE ANDROGENS CONFER RESISTANCE TO ENZALUTAMIDE
21. MP46-02 UP-REGULATION OF GLUCOSE METABOLISM BY NF-κB2/P52 MEDIATES ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER CELLS
22. MP46-05 INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 AND AR VARIANTS REVERSES ENZALUTAMIDE RESISTANCE IN ADVANCED PROSTATE CANCER CELLS
23. MP46-03 NF-KAPPAB2/P52:C-MYC:HNRNPA1 REGULATORY PATHWAY CONTROLS EXPRESSION OF ANDROGEN RECEPTOR SPLICE VARIANTS AND ENZALUTAMIDE SENSITIVITY IN PROSTATE CANCER
24. MP24-08 INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS
25. MP24-07 NF-KAPPAB2/P52 INDUCES RESISTANCE TO ENZALUTAMIDE IN PROSTATE CANCER: ROLE OF ANDROGEN RECEPTOR AND ITS VARIANTS
26. 1322 LIN28 PROMOTES GROWTH OF PROSTATE CANCER CELLS AND ACTIVATES THE ANDROGEN RECEPTOR
27. 1327 NF-κB2/P52 INDUCES RESISTANCE TO ENZALUTAMIDE POSSIBLY BY UPREGULATION OF AR-V7
28. 974 FUNCTIONAL P53 DETERMINES DOCETAXEL SENSITIVITY IN PROSTATE CANCER CELLS
29. 975 MIR-LET-7C AXIS REGULATES ANDROGEN SIGNALING AND THE GROWTH OF PROSTATE CANCER CELLS
30. 782 SANGUINARINE INHIBITS STAT3 ACTIVATION AND TUMOR GROWTH IN PROSTATE CANCER CELLS
31. 483 RHOGDIÁ SUPPRESSES GROWTH AND SURVIVAL OF PROSTATE CANCER CELLS BY REGULATING ANDROGEN RECEPTOR (AR) SIGNALING PATHWAY
32. 1619 ANDROGRAPHOLIDE IS A NOVEL INHIBITOR OF INTERLEUKIN-6 AND SUPPRESSES PROSTATE TUMOR GROWTH
33. 1622 LIN28/MIR-LET-7C AXIS CONTROLS THE GROWTH AND TUMORIGENICITY OF PROSTATE CANCER CELLS
34. 415 ANDROGRAPHOLIDE TARGETS AR PATHWAY IN CASTRATION-RESISTANT PROSTATE CANCER
35. NF-KB2/P52 INDUCES CASTRATION-RESISTANT PROSTATE CANCER CELL GROWTH AND ABERRANT ACTIVATION OF ANDROGEN RECEPTOR
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.